These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10476660)

  • 1. [The use of substitute surfactant therapy in treating acute destructive pneumonia in children].
    Protsiuk RG; Dzhansyz KN
    Lik Sprava; 1999 Jun; (4):117-21. PubMed ID: 10476660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of the exogenous surfactant curosurf in combined therapy for acute respiratory failure in children after cardiosurgical interventions].
    Lobacheva GV; Khar'kin AV; Aksenov AV; Kvasnikov BB; Manerova AF; Bokeriia LA
    Anesteziol Reanimatol; 2005; (3):35-8. PubMed ID: 16076044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Our experience in the use of a Russian preparation of pulmonary surfactant in the treatment of acute respiratory distress syndrome and severe pneumonia in children].
    Tsybul'kin EK; Rozenberg OA; Seĭliev AA; Volchkov VA; Zaĭtseva NV; Kuz'menko IG; Loshakova LV; Pelogievskaia ZI; Portniagin IV; Shefer SP
    Anesteziol Reanimatol; 1999; (2):61-5. PubMed ID: 10360078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint Intratracheal Surfactant-Antibacterial Therapy in Experimental Pseudomonas-Induced Pneumonia.
    Birkun AA; Kubyshkin AV; Novikov NY; Krivorutchenko YL; Fedosov MI; Postnikova ON; Snitser AA
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):299-307. PubMed ID: 25517041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An evaluation of the effect of magnetic-laser therapy on external respiratory function in complicated forms of acute pneumonia in children].
    Gaĭdashev EA; Lebedev KN; Khristoforov VN; Biriukov VV; Gatkin EIa
    Vopr Kurortol Fizioter Lech Fiz Kult; 1995; (3):12-4. PubMed ID: 7483376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant replacement therapy for preterm and term neonates with respiratory distress.
    Polin RA; Carlo WA; ;
    Pediatrics; 2014 Jan; 133(1):156-63. PubMed ID: 24379227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia.
    Ambroggio L; Taylor JA; Tabb LP; Newschaffer CJ; Evans AA; Shah SS
    J Pediatr; 2012 Dec; 161(6):1097-103. PubMed ID: 22901738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute suppurative destructive pneumonias in children].
    Sergeev VM; Levin AB; Bondarchuk LG; Manzhos PI; Lukina NL
    Vestn Khir Im I I Grek; 1986 Oct; 137(10):78-83. PubMed ID: 3798670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pulmonary surfactant in acute pneumonia in children].
    Birkun AA; Kobozev GV; Molotkova GV; Safronova LG
    Pediatriia; 1982; (9):14-7. PubMed ID: 6897291
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial.
    Willson DF; Thomas NJ; Markovitz BP; Bauman LA; DiCarlo JV; Pon S; Jacobs BR; Jefferson LS; Conaway MR; Egan EA;
    JAMA; 2005 Jan; 293(4):470-6. PubMed ID: 15671432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous surfactant therapy in newborns.
    Rodriguez RJ; Martin RJ
    Respir Care Clin N Am; 1999 Dec; 5(4):595-616. PubMed ID: 10565883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination therapy of high frequency oscillatory ventilation, NO inhalation and surfactant replacement in a child with acute respiratory distress syndrome].
    Merz U; Schefels J; Hendricks H; Hörnchen H
    Klin Padiatr; 1999; 211(2):83-5. PubMed ID: 10407817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of treatment with surfactant in premature infants with respiratory failure and pulmonary infection.
    Vento G; Tana M; Tirone C; Aurilia C; Lio A; Perelli S; Ricci C; Romagnoli C
    Acta Biomed; 2012; 83 Suppl 1():33-6. PubMed ID: 23029875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant replacement therapy for adult respiratory distress syndrome in children.
    Evans DA; Wilmott RW; Whitsett JA
    Pediatr Pulmonol; 1996 May; 21(5):328-36. PubMed ID: 8726159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects on the pulmonary function after single dose of exogenous pulmonary surfactant in children with acute respiratory distress syndrome].
    de Carvalho WB; Mângia CM
    Rev Assoc Med Bras (1992); 1997; 43(2):145-150. PubMed ID: 9336050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of pulmonary surfactant in treatment of acute lung injury after cardiac surgery in infants].
    Hong XY; Kong XY; Zhou GX; Liu YH; Yang XY; Feng ZC
    Zhonghua Er Ke Za Zhi; 2012 Mar; 50(3):193-6. PubMed ID: 22801200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience in treating suppurative-destructive pneumonias in children].
    Bannikov MIu; Vereiutin IuM; Doronin VF; Zhukov EA
    Vestn Khir Im I I Grek; 1990 Nov; 145(11):83-4. PubMed ID: 1966186
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of exogenous surfactant in the treatment of acute lung injury.
    Lewis JF; Veldhuizen R
    Annu Rev Physiol; 2003; 65():613-42. PubMed ID: 12517997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of the early stages of acute destructive pneumonia in children].
    Mavliutova MG; Iuldashev MT; Konovalova GM
    Khirurgiia (Mosk); 1985 Jul; (7):56-9. PubMed ID: 4046422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.